The Mechanism of Rosiglitazone on Regulation of the Secretion of Cytokines in Macrophage
碩士 === 國立臺灣大學 === 分子醫學研究所 === 92 === Rosiglitazone (RSG) is a synthetic PPARγ agonist, possessing the effect of lowering blood sugar. It is used clinically to treat type 2 diabetes. PPARγ has a restricted pattern of expression, mainly in the white and brown adipose tissues, whereas other tissues suc...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2004
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/92371336254816316571 |